Close the gap between disease insight and actionable data.
Disease is heterogeneous, and building hypotheses on incomplete information risks misdirecting programs and costly pivots later on. See how closing the gap between what you need to understand about a disease and what you can actually measure translates into more confident decisions, from early target identification through translational validation.
Why download the brochure?
- Build confidence in target and biomarker decisions earlier, before they become expensive pivots later in development
- See how a more complete, cell-by-cell view of disease biology strengthens the foundation for clinical advancement
- Access one toolkit spanning CRISPR screening, single cell, and spatial multiomics, so the technology matches the biological question, not the other way around
- Explore real oncology and drug discovery programs putting this approach into practice today
